Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Healthcare, engineering and specialty chemicals remain key market themes: Mayuresh Joshi
Mayuresh Joshi, Director Research at Marketsmith India, believes execution will remain key for companies like Suzlon, while healthcare, engineering and select speciality chemical names continue to offer strong growth opportunities. He also sees India-focused engineering and capital goods companies remaining resilient despite global uncertainties. Joshi says investors should stay selective in IT, remains positive on Navin Fluorine, and is closely tracking niche AI-linked opportunities emerging in smaller tech firms.
1080% returns in five years! Multibagger stock rises despite cautious trends on Dalal Street
Himadri Speciality Chemical shares gained nearly 2% to ₹590 after announcing an investment in Sicona Battery Technologies. The company has invested AUD 25.59 lakh in additional Compulsorily Convertible Notes, raising its total to 1.67 crore CCNs, while maintaining no additional voting rights.
Sun Pharma Q4 Preview: Can Unloxcyt and speciality drugs help pharma major deliver another strong quarter?
Sun Pharma is expected to post double-digit revenue growth in Q4FY26, driven by strong performance across speciality drugs, domestic formulations, and emerging markets. Brokerages highlight US portfolio strength, new launches like Unloxcyt, and a steady margin outlook despite higher R&D spending, with EBITDA growth supported by diversified global business momentum outlook
Why PSU banks look stronger than private lenders right now: PL Capital’s Amisha Vora explains
Amisha Vora, Chairperson & MD, PL Capital, believes PSU banks look more attractive than private banks due to their stronger ability to raise low-cost deposits. She is positioning portfolios toward exporters, metals, defence and power-linked sectors amid sharp rupee depreciation. Vora also sees opportunities in niche auto ancillaries, speciality pharma and engineering exporters, while remaining cautious on IT and broader consumer durable plays due to weak growth visibility and rising competition.
Alembic Pharma bets on branded drugs in the US
While the company hopes to push into branded speciality drugs, which offer a better value proposition in the US, its core generics business will continue to remain a priority
Park Medi World Q4 Results: Stock gives up initial spurt despite revenue growth, margin expansion
The group now consolidates 22 subsidiaries, spanning hospital brands including Aggarwal Hospital, Blue Heavens Healthcare, Park Medicity, Kailash Super-Speciality, and Umkal Healthcare, among others.
Shyam Metalics Q4 Results: Profit rises 46%; board clears ₹2,700 crore capex
Shyam Metalics and Energy reported strong Q4 earnings growth with higher margins and announced a ₹2,700 crore expansion plan aimed at boosting speciality steel and stainless steel capacities.
Himadri Speciality shares jump 6% to hit a 52-week high after a 38% rise in April amid focus on revenue growth - Mint
Himadri Speciality shares jump 6% to hit a 52-week high after a 38% rise in April amid focus on revenue growthMint
Himadri Speciality Q4 Results | Net profit surges 29% on higher revenue; declares dividend
Shares of Himadri Speciality Chemical Ltd ended at ₹537.50, up by ₹14.55, or 2.78%, on the BSE.
Stocks to Watch for April 24: Infosys, Tata Capital, LTM, Adani Energy Solutions, Cyient and more
Infosys, LTIMindtree, Tata Capital, Adani Energy Solutions, Cyient, Mahindra Logistics and Himadri Speciality Chemical post mixed Q4, key earnings from Reliance and others due April 24. Here are few stocks to keep an eye on ahead of Friday's trading session.
Ambuja Neotia Group to develop over Rs 700 cr integrated healthcare and hospitality project in Guwahati
Ambuja Neotia Group will build a large integrated healthcare and hospitality project in Guwahati. The Rs 700 crore investment will include a 300-bed multi-speciality hospital and a 4+ star hotel. This initiative aims to boost the region's healthcare infrastructure and economy. The project is expected to create thousands of jobs. It marks the group's second healthcare venture in Assam.
HMEL to invest Rs 2,600 cr in speciality, fine chemicals sector in Punjab: LN Mittal
HPCL-Mittal Energy Limited (HMEL) announced a Rs 2,600 crore investment in Punjab's speciality and fine chemicals sector. Additionally, HMEL plans to launch 500 new retail fuel outlets nationwide, equipped with modern technology. This expansion follows HMEL's significant Rs 60,000 crore investment in its Bathinda refinery, Punjab's sole oil refinery.